Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Asfotase Alfa

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alexion Pharma's Biologic Strensiq (asfotase alfa) Receives Approval in US
    Alexion Pharma's Biologic Strensiq (asfotase alfa) Receives Approval in US

    10 Jul 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125513

    FDA
    10 Jul 2024
    Share Share
    NICE recommends Alexion’s asfotase alfa across England
    NICE recommends Alexion’s asfotase alfa across England

    27 Jan 2023

    // PHARMATIMES

    https://www.pharmatimes.com/news/nice_recommends_alexions_asfotase_alfa_across_england_1485973

    PHARMATIMES
    27 Jan 2023
    Share Share
    Alexion`s Strensiq (Asfotase Alfa) Receives Supplemental Approval in US
    Alexion`s Strensiq (Asfotase Alfa) Receives Supplemental Approval in US

    17 Jun 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125513

    FDA
    17 Jun 2020
    Share Share
    Abeona Therapeutics Announces Leadership Appts with Max Colao as CCO
    Abeona Therapeutics Announces Leadership Appts with Max Colao as CCO

    30 Jul 2018

    // GLOBENEWSWIRE

    https://globenewswire.com/news-release/2018/07/26/1542695/0/en/Abeona-Therapeutics-Announces-Leadership-Appointments-with-Max-Colao-as-Chief-Commercial-Officer.html

    GLOBENEWSWIRE
    30 Jul 2018
    Share Share